Articles by Philip Ridley-Smith - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

Articles by Philip Ridley-Smith

Biosimilars Regulation in the US: The Challenges

The pathway for biosimilar approval in the US has been set. But are US patients too far behind Europe?
Nov 1, 2010

The pathway for biosimilar approval in the US has been set. But are US patients too far behind Europe?

ADVERTISEMENT

ADVERTISEMENT

Click here